Pelthos Therapeutics Inc. (PTHS) Net Margin
- 2026-06-30: Net Margin -150.08%.
- 2026-03-31: Net Margin -229.90%.
- 2025-12-31: Net Margin -131.29%.
- 2025-09-30: Net Margin -5523.13%.
Complete source-backed net margin history.
- Available history
- 2025-09-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -150.08% |
| 2026-03-31 | -229.90% |
| 2025-12-31 | -131.29% |
| 2025-09-30 | -5523.13% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -257.93% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |